BOM logo

BOM

Europe, Noord-Brabant, The Netherlands, Tilburg

Description

BOM invests in innovative start-up and growth companies, to improve the economic structure in the province of Brabant.

Investor Profile

BOM has made 123 investments, with 8 in the past 12 months and 21% as lead.

Stage Focus

  • Seed (34%)
  • Series Unknown (34%)
  • Series A (14%)
  • Series B (8%)
  • Pre Seed (4%)
  • Convertible Note (2%)
  • Angel (2%)
  • Debt Financing (1%)
  • Series C (1%)

Country Focus

  • The Netherlands (95%)
  • United States (4%)
  • United Kingdom (1%)

Industry Focus

  • Health Care
  • Medical
  • Manufacturing
  • Biotechnology
  • Medical Device
  • Software
  • Nanotechnology
  • Information Technology
  • Energy
  • Logistics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BOM frequently co-invest with?

Thuja Capital
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 7
Point-One Innovation Fund
Europe, Noord-Brabant, The Netherlands, Eindhoven
Co-Investments: 3
Curie Capital
North America, Missouri, United States, Netherlands
Co-Investments: 4
imec.xpand
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
Invest-NL
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 7
TIIN Capital
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 5
BS
Europe, Noord-Brabant, The Netherlands, 's-hertogenbosch
Co-Investments: 3
BioGeneration Ventures
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 7
Innovation Industries
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
Holland Capital
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 5

Which angels does BOM often collaborate with?

David Pyott
North America, California, United States, Orange
Shared Deals: 1
Shared Deals: 1
SB
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
WV
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
WM
Europe, Utrecht, The Netherlands, Utrecht
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by BOM?

Salvia BioElectronics

Eindhoven, Noord-Brabant, The Netherlands

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

BiotechnologyMedical DeviceTherapeutics
Series BMay 27, 2025
Amount Raised: $60,425,647
FononTech

Eindhoven, Noord-Brabant, The Netherlands

FononTech is an impulse printing company that produces fine-grained patterns in the micro to millimeter range for electronics.

ElectronicsIndustrial ManufacturingMachinery Manufacturing
SeedMay 16, 2025
Amount Raised: $9,487,761

Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations.

SeedMay 7, 2025
Amount Raised: $17,043,498
Astrape Networks

Eindhoven, Noord-Brabant, The Netherlands

Astrape powers the future of datacenters: more bandwidth, less power.

Optical CommunicationSemiconductorTelecommunications
SeedApr 29, 2025
Amount Raised: $6,152,865
Avidicure

South Holland, Illinois, United States

Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.

SeedApr 24, 2025
Amount Raised: $50,000,000
Sirius Medical

Eindhoven, Noord-Brabant, The Netherlands

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment.

Health CareMedicalMedical Device
Series UnknownFeb 4, 2025
Amount Raised: $10,332,350
PHOTON IP

Eindhoven, Noord-Brabant, The Netherlands

chipmaker for advanced optical chips

Optical CommunicationSemiconductor
SeedJan 13, 2025
Amount Raised: $4,852,435
Citryll

Oss, Noord-Brabant, The Netherlands

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

BiopharmaBiotechnologyMedicalMedical DeviceNeuroscience
Series BDec 9, 2024
Amount Raised: $89,720,936
Antennex

Eindhoven, Noord-Brabant, The Netherlands

RF, Test and Measurement Equipement,

Test and Measurement
SeedOct 29, 2024
Amount Raised: $1,622,990
Kivu Bioscience

San Francisco, California, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

BiotechnologyHealth CareOncology
Series AOct 28, 2024
Amount Raised: $92,000,000